Exact Mass: 625.0845

Exact Mass Matches: 625.0845

Found 13 metabolites which its exact mass value is equals to given mass value 625.0845, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Afoxolaner

2-[(4-{5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl}naphthalen-1-yl)formamido]-N-(2,2,2-trifluoroethyl)ethanimidic acid

C26H17ClF9N3O3 (625.0815)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent Afoxolaner is an orally active isoxazoline insecticide/acaricide against Ixodes scapularis in dogs. Afoxolaner acts on the insect γ-aminobutyric acid receptor (GABA) and glutamate receptors, inhibiting GABA & glutamate-regulated uptake of chloride ions, resulting in excess neuronal stimulation and death of the arthropod[1][2].

   

Vancomycinic acid

Vancomycinic acid

C26H25Cl2N3O11 (625.0866)


   

HR 111V sulfate

HR 111V sulfate

C23H25N6O9S3 (625.0845)


   

SR 9243

N-(3-Bromophenethyl)-2,4,6-trimethyl-N-((3-(methylsulfonyl)-[1,1-biphenyl]-4-yl)methyl)benzenesulfonamide

C31H32BrNO4S2 (625.0956)


SR9243 is a liver-X-receptor (LXR) inverse agonist that induces LXR-corepressor interaction.

   

Milvexian

Milvexian

C28H23Cl2F2N9O2 (625.132)


C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent

   

Afoxolaner

Afoxolaner

C26H17ClF9N3O3 (625.0815)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent Afoxolaner is an orally active isoxazoline insecticide/acaricide against Ixodes scapularis in dogs. Afoxolaner acts on the insect γ-aminobutyric acid receptor (GABA) and glutamate receptors, inhibiting GABA & glutamate-regulated uptake of chloride ions, resulting in excess neuronal stimulation and death of the arthropod[1][2].

   

2-O-crotonyl-ADP-D-ribose

2-O-crotonyl-ADP-D-ribose

C19H25N5O15P2-2 (625.0822)


   

6-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]-1-S-[(1Z)-5-(methanesulfinyl)-N-sulfopent-4-enimidoyl]-1-thio-beta-D-glucopyranose

6-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]-1-S-[(1Z)-5-(methanesulfinyl)-N-sulfopent-4-enimidoyl]-1-thio-beta-D-glucopyranose

C23H31NO13S3 (625.0957)


   

5-Chlorosulfonyl-2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)benzenesulfonic acid

5-Chlorosulfonyl-2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)benzenesulfonic acid

C31H30ClN2O6S2+ (625.1234)


   

P-dThd-P-m5Cyt-dRibf

P-dThd-P-m5Cyt-dRibf

C20H29N5O14P2 (625.1186)


   

6-Sinapoylglucoraphenin

6-Sinapoylglucoraphenin

C23H31NO13S3 (625.0957)


A glucosinolic acid that is glucoraphenin in which the hydroxy hydrogen at position 6 on the glucose fragment has been replaced by a sinapoyl group.

   

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(1z)-5-methanesulfinyl-1-(sulfoimino)pent-4-en-1-yl]sulfanyl}oxan-2-yl]methyl (2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(1z)-5-methanesulfinyl-1-(sulfoimino)pent-4-en-1-yl]sulfanyl}oxan-2-yl]methyl (2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

C23H31NO13S3 (625.0957)


   

[12-(4-hydroxy-3-methoxyphenyl)-8,16,17,18-tetramethoxy-3-oxo-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-7-yl]oxidanesulfonic acid

[12-(4-hydroxy-3-methoxyphenyl)-8,16,17,18-tetramethoxy-3-oxo-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-7-yl]oxidanesulfonic acid

C30H27NO12S (625.1254)